Literature DB >> 217955

Decreased production of transforming virus and altered antigenic behaviour in cultured avian sarcoma cells.

M A Wainberg, M Yu, E Israel.   

Abstract

Tumours induced in chickens by inoculation of avian sarcoma viruses are frequently capable of undergoing spontaneous regression. It is only those tumour cells which have been derived from progressively growing neoplasms that are able to produce transforming progeny virus in vitro and to shed into the culture medium antigens which are specifically reactive with the peripheral lymphocytes of sarcoma-bearing hosts. Following multiple passages and extended growth in culture, however, the ability of these tumour cell fluids to stimulate the lymphocytes of sensitized hosts diminishes in concert with the declining capacity of these cells to continue to synthesize fully transforming progeny virus. In certain instances, however, aged tumour cells are able to synthesize particles which contain the enzyme RNA-dependent DNA polymerase yet lack detectable envelope glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217955     DOI: 10.1099/0022-1317-42-2-255

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Non-specific inhibition by virus particles of human lymphocytes mitogenesis.

Authors:  R G Margolese; E Israel; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

2.  Further studies on the mitogenic and immune-modulating effects of plasminogen activator.

Authors:  M A Wainberg; E Israel; R G Margolese
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

3.  Viral abrogation of lymphocyte mitogenesis: induction of a soluble factor inhibitory to cellular proliferation.

Authors:  E Israel; B Beiss; M A Wainberg
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

4.  Loss of transformed phenotype upon senescence of Rous sarcoma virus-infected chicken neuroretinal cells.

Authors:  G M Seigel; M F Notter
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.